About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - ANTISENSE THERAPEUTICS LIMITED
ANTISENSE THERAPEUTICS LIMITED
Health Care
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
62.10m
Price at Close
$0.127
4w avg. Volume
1.96m
4w avg. Turnover
$261.00k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| - | 22 Oct 2020 |
| - | 22 Oct 2020 |
| -5.93% | 20 Oct 2020 |
| -5.93% | 20 Oct 2020 |
| -8.70% | 02 Oct 2020 |
| -16.00% | 01 Oct 2020 |
| +8.70% | 29 Sep 2020 |
| +8.70% | 29 Sep 2020 |
| +26.09% | 27 Sep 2020 |
| +5.00% | 22 Sep 2020 |
Market Data
Current Price
$0.127
52WK HIGH
$0.16
52WK LOW
$0.029
1YR RETURN
+27.00%
1YR RETURN VS. SECTOR
+8.26%
90 DAY RETURN
+27.00%
ASX RANK
976
/2,010
SECTOR RANK
12
/31
SHARES OUTSTANDING
488.99m
ANTISENSE THERAPEUTICS LIMITED
Health Care
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
Read moreMarket Cap
62.10m
Price at Close
$0.127
4w avg. Volume
1.96m
4w avg. Turnover
$261.00k
ASX:ANP is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia